CIK 0001645460 · Non-accelerated filer<br>Smaller reporting company
Cue Biopharma, Inc.
Sign in to watch- Ticker
- CUE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473324577
- Phone
- 617-949-2680
- Business address
- 100 CHESTNUT STREET, SUITE 300, SOMERVILLE, MA, 02143
- Former names
- Imagen Biopharma, Inc.
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 144 Insider Sale of Securities
- S-3 Offering Registration Statement
- 8-K Event Executive or director change
- 4 Grant or award Chief Financial Officer acquired 25,500 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4/A Derivatives Options or other derivatives
- D Other Notice of Sales of Unregistered Securities
- 4 Grant or award Chief Medical Officer acquired 31,500 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 21,800 shares (grant or award)
- 4 Grant or award Director acquired 21,800 shares (grant or award)
- 4 Grant or award Director acquired 21,800 shares (grant or award)
- 4 Grant or award Director acquired 21,800 shares (grant or award)
- 4 Grant or award VP, Prin. Accounting Officer acquired 40,942 shares (grant or award)
- 4 Grant or award Chief Legal Compliance Officer acquired 54,589 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 327,537 shares (grant or award)
- 8-K Event Material agreement · Unregistered share sale · Executive or director change · Other events
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
Page 2 of 28 · 553 filings